Human TMEM174 that is highly expressed in kidney tissue activates AP-1 and promotes cell proliferation

Biochemical and Biophysical Research Communications

Volumn 394, Issue 4, 2010, Pages 993-999

  Wang, Pingzhang ^a,b,c   Sun, Bo ^d   Hao, Dongxia ^d   Zhang, Xiujun ^d   Shi, Taiping ^a,b,c   Ma, Dalong ^a,b,c  

^a CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY   (China)

^d NORTH CHINA COAL MEDICAL COLLEGE   (China)

Author keywords

AP 1; Cell proliferation; ELK1; Kidney; TMEM174

Indexed keywords

MEMBRANE PROTEIN; RNA; TRANSCRIPTION FACTOR AP 1; TRANSMEMBRANE PROTEIN 174; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY DEVELOPMENT; KIDNEY PARENCHYMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA TRANSCRIPTION;

AMINO ACID SEQUENCE; CELL LINE; CELL PROLIFERATION; CLONING, MOLECULAR; ENDOPLASMIC RETICULUM; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KIDNEY; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 77950864046     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.109     Document Type: Article

References (25)

1. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
2. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
3. Hess J., Angel P., and Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117 (2004) 5965-5973
4. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
5. Herdegen T., and Waetzig V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20 (2001) 2424-2437
6. Angel P., Szabowski A., and Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 20 (2001) 2413-2423
7. Ashida R., Tominaga K., Sasaki E., Watanabe T., Fujiwara Y., Oshitani N., Higuchi K., Mitsuyama S., Iwao H., and Arakawa T. AP-1 and colorectal cancer. Inflammopharmacology 13 (2005) 113-125
8. Matthews C.P., Colburn N.H., and Young M.R. AP-1 a target for cancer prevention. Curr. Cancer Drug Targets 7 (2007) 317-324
9. Muller D.N., Shagdarsuren E., Park J.K., Dechend R., Mervaala E., Hampich F., Fiebeler A., Ju X., Finckenberg P., Theuer J., Viedt C., Kreuzer J., Heidecke H., Haller H., Zenke M., and Luft F.C. Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am. J. Pathol. 161 (2002) 1679-1693
10. Le N.H., van der Wal A., van der Bent P., Lantinga-van Leeuwen I.S., Breuning M.H., van Dam H., de Heer E., and Peters D.J. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 16 (2005) 2724-2731
11. Vrtovsnik F., Couette S., Prie D., Lallemand D., and Friedlander G. Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway. Kidney Int. 52 (1997) 1016-1027
12. Mezzano S.A., Barria M., Droguett M.A., Burgos M.E., Ardiles L.G., Flores C., and Egido J. Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int. 60 (2001) 1366-1377
13. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
14. Tian W., Zhang Z., and Cohen D.M. MAPK signaling and the kidney. Am. J. Physiol. Renal Physiol. 279 (2000) F593-F604
15. Hida M., Omori S., and Awazu M. ERK and p38 MAP kinase are required for rat renal development. Kidney Int. 61 (2002) 1252-1262
16. Awazu M., Omori S., and Hida M. MAP kinase in renal development. Nephrol. Dial. Transplant. 17 Suppl. 9 (2002) 5-7
17. Vaidya V.S., Shankar K., Lock E.A., Dixon D., and Mehendale H.M. Molecular mechanisms of renal tissue repair in survival from acute renal tubule necrosis: role of ERK1/2 pathway. Toxicol. Pathol. 31 (2003) 604-618
18. Ma X., Wang X., Gao X., Wang L., Lu Y., Gao P., Deng W., Yu P., Ma J., Guo J., Cheng H., Zhang C., Shi T., and Ma D. Identification of five human novel genes associated with cell proliferation by cell-based screening from an expressed cDNA ORF library. Life Sci. 81 (2007) 1141-1151
19. Gille H., Kortenjann M., Thomae O., Moomaw C., Slaughter C., Cobb M.H., and Shaw P.E. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14 (1995) 951-962
20. Cavigelli M., Dolfi F., Claret F.X., and Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14 (1995) 5957-5964
21. Zsurka G., Gregan J., and Schweyen R.J. The human mitochondrial Mrs2 protein functionally substitutes for its yeast homologue, a candidate magnesium transporter. Genomics 72 (2001) 158-168
22. Goytain A., and Quamme G.A. Identification and characterization of a novel family of membrane magnesium transporters, MMgT1 and MMgT2. Am. J. Physiol. Cell. Physiol. 294 (2008) C495-C502
23. Lastro M., Kourtidis A., Farley K., and Conklin D.S. xCT expression reduces the early cell cycle requirement for calcium signaling. Cell Signal. 20 (2008) 390-399
24. Shin M.K., Kim M.K., Bae Y.S., Jo I., Lee S.J., Chung C.P., Park Y.J., and Min do S. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells. Cell Signal. 20 (2008) 613-624
25. Quintana A., Griesemer D., Schwarz E.C., and Hoth M. Calcium-dependent activation of T-lymphocytes. Pflugers Arch. 450 (2005) 1-12